Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group
  • International Quantum Electronics Conference
  • OSA Technical Digest (Optica Publishing Group, 1984),
  • paper WII22

BASIC AND CLINICAL STUDIES WITH HEMATOPORPHYRIN DERIVATIVE PHOTORADIATION THERAPY (HPD-PRT)

Not Accessible

Your library or personal account may give you access

Abstract

In the three years that we have been employing HPD-PRT, 149 patients have been treated at 588 different sites. The locations of the malignancies have fallen primarily into the following anatomical regions: chest wall (breast cancer recurrences), head and neck (oral cavity, nasopharynx, vocal cords), lung, female genital (cervix, vagina, vulva), and miscellaneous areas that Included cancers such as Kaposi sarcoma, melanoma, basal cell nevus, angiosarcoma, and Merkel cell carcinoma. Seventy-two percent of all sites showed a favorable response (partial or complete response). For individual anatomical groups the percent favorable response were as follows: chest wall, 83%; head and neck, 53%; lung, 67%; genital, 67%; and miscellaneous, 32%.

© 1984 Optical Society of America

PDF Article
More Like This
Treatment of intraocular tumors with hematoporphyrin derivative photoradiation therapy.

Charles J. Gomer, A. Linn Murphree, Daniel R. Doiron, Nicholas J. Razum, and Stanley W. Fountain
FG2 Conference on Lasers and Electro-Optics (CLEO:S&I) 1984

Treatment of Intraocular Tumors with Hematoporphyrin-Derivative Photoradiation Therapy

Charles J. Gomer, A. Linn Murphree, Daniel R. Doiron, Nicholas J. Razum, and Stanley W. Fountain
FG2 International Quantum Electronics Conference (IQEC) 1984

Mechanisms of the hematoporphyrin-derivative (HpD)-induced photodamage of neoplastic cells: fluorescence studies

G. Bottiroli, I. Freitas, F. Docchio, R. Ramponi, and C. A. Sacchi
FB5 Conference on Lasers and Electro-Optics (CLEO:S&I) 1984

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.